The Great Divide in Pakistan Pharma Market – Suggestions for Smaller Companies – Asrar Qureshi’s Blog Post #1321

Asrar Qureshi’s Blog Post #1321 discusses strategies for smaller pharmaceutical companies in Pakistan to gain market traction amidst larger competitors. Key recommendations include focusing on specific therapeutic areas, establishing a flagship brand, differentiating offerings, enhancing doctor relationships, leveraging digital tools, forming partnerships, and optimizing resource allocation to build a credible market presence.
Share
View Post
  • 6 min

Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320

Pakistan’s pharmaceutical market is highly concentrated, with the top 50 companies holding nearly 90% of sales, leaving many smaller firms struggling. This disparity affects competition, innovation, and talent acquisition. Smaller firms often resort to survival strategies rather than growth, highlighting a need for stronger capabilities rather than just more companies.
Share
View Post
  • 6 min

Why Should Childhood Cancer Survival Depend on Where the Child is Born? – Asrar Qureshi’s Blog Post #1319

The WHO’s 2026 report on childhood cancer highlights significant survival disparities globally, urging that access to timely diagnosis, treatment, and continuous care should not depend on geography. The initiative targets a 60% survival rate by 2030, emphasizing data collection and coordinated action to improve health systems and outcomes for affected children.
Share
View Post
  • 6 min

Women are Living Longer, But are they Living healthier? – Asrar Qureshi’s Blog Post #1318

Asrar Qureshi’s blog highlights a Boston Consulting Group study revealing that while women live longer, they experience significantly more years in poor health than men. The $350 billion market in women’s longevity faces unmet needs due to inadequate solutions, indicating a critical healthcare gap requiring focused innovations for better health outcomes.
Share
View Post
  • 5 min

Turning Organizational Values into Everyday Behavior – Asrar Qureshi’s Blog Post #1317

Asrar Qureshi’s blog post emphasizes the importance of integrating organizational values into everyday practices. It offers strategies such as defining non-negotiable boundaries, aligning incentives with values, and fostering a culture where bad news is communicated openly. The author’s framework aims to build a sustainable values-driven culture within organizations.
Share
View Post
  • 6 min

From Values on the Wall to Values Under Pressure – Asrar Qureshi’s Blog Post #1316

This blog post emphasizes the importance of organizational values, particularly in challenging situations. It argues that values are truly tested when leaders face conflicts between principles and performance. A refusal framework helps define not only what organizations stand for, but also what they will not sacrifice for profit. Insights on psychological safety are also highlighted.
Share
View Post
  • 5 min

Manager Visibility is Not Enough for Leadership – Asrar Qureshi’s Blog Post #1315

Asrar Qureshi’s blog post emphasizes that management visibility alone does not solve problems; substantive action is necessary after identifying them. A Harvard study shows that merely recognizing issues without addressing them can harm employee morale. The goal should be to foster a culture of continuous problem-solving rather than merely collecting issues.
Share
View Post
  • 6 min

New Thinking on Burnout – Asrar Qureshi’s Blog Post #1314

Asrar Qureshi’s blog post discusses the paradox of burnout, highlighting that those passionate about their professions can be especially vulnerable. It emphasizes the importance of managing expectations versus reality in work, advocating for a balanced life where work is meaningful but not the entirety of one’s identity. Overall, sustainability is key to preventing burnout.
Share
View Post
  • 6 min

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313

Asrar Qureshi’s blog delves into the complex journey of health innovations from discovery to patient access, highlighting the significant costs and time involved in drug development. It emphasizes the need for a collaborative approach between pharmaceutical companies and governments to address pricing, making life-saving medications accessible while managing risks and uncertainties effectively.
Share
View Post
  • 6 min

Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312

Asrar Qureshi’s blog discusses the MARS mission, emphasizing that improving access to existing cancer care technologies may be more crucial than new discoveries. Key issues include disparities in patient access, the need for decentralized clinical trials, and the importance of early detection and international collaboration to address the global cancer crisis effectively.
Share